Suppr超能文献

非酒精性脂肪性肝病患者的红细胞条件培养基中MCP1含量增加并诱导TNF-α释放。

Red Blood Cell-Conditioned Media from Non-Alcoholic Fatty Liver Disease Patients Contain Increased MCP1 and Induce TNF-α Release.

作者信息

Papadopoulos Charalampos, Mimidis Konstantinos, Papazoglou Dimitris, Kolios George, Tentes Ioannis, Anagnostopoulos Konstantinos

机构信息

Laboratory of Biochemistry, Department of Medicine, Democritus University of Thrace, Greece.

Pathology Clinic, Department of Medicine, Democritus University of Thrace, Greece.

出版信息

Rep Biochem Mol Biol. 2022 Apr;11(1):54-62. doi: 10.52547/rbmb.11.1.54.

Abstract

BACKGROUND

Non-alcoholic fatty liver disease (NAFLD) constitutes a global pandemic. An intricate network among cytokines and lipids possesses a central role in NAFLD pathogenesis. Red blood cells comprise an important source of both cytokines and signaling lipids and have an important role in molecular crosstalk during immunometabolic deregulation. However, their role in NAFLD has not been thoroughly investigated.

METHODS

Conditioned media from erythrocytes derived from 10 NAFLD patients (4 men, 6 women, aged 57.875±15.16) and 10 healthy controls (4 men, 6 women, aged 39.3±15.55) was analyzed for the cytokines IFN-γ, TNF-α, CCL2, CCL5, IL-8, IL-1β, IL-12p40, IL-17, MIP-1β, the signaling lipids sphingosine-1-phosphate (S1P) and lysophosphatidic acid (LPA), and cholesterol. Their effect on the cytokine profile released by RAW 264.7 macrophages was also studied.

RESULTS

MCP1 levels were greater in conditioned growth medium from NAFLD patient erythrocytes than in that from healthy controls (37±40 vs 6.51±5.63 pg/ml). No statistically significant differences were found between patients and healthy controls with regard to S1P, LPA, cholesterol, or eight other cytokines. TNF-a release by RAW 264.7 cells was greater after incubation with patient-derived erythrocyte-conditioned medium than in medium without RAW 264.7 cells from either healthy or NAFLD subjects.

CONCLUSION

Erythrocytes may contribute to liver infiltration by monocytes, and macrophage activation, partially due to CCL2 release, in the context of NAFLD..

摘要

背景

非酒精性脂肪性肝病(NAFLD)是一种全球性流行病。细胞因子和脂质之间的复杂网络在NAFLD发病机制中起核心作用。红细胞是细胞因子和信号脂质的重要来源,在免疫代谢失调期间的分子串扰中起重要作用。然而,它们在NAFLD中的作用尚未得到充分研究。

方法

分析了10名NAFLD患者(4名男性,6名女性,年龄57.875±15.16岁)和10名健康对照者(4名男性,6名女性,年龄39.3±15.55岁)红细胞的条件培养基中的细胞因子IFN-γ、TNF-α、CCL2、CCL5、IL-8、IL-1β、IL-12p40、IL-17、MIP-1β、信号脂质鞘氨醇-1-磷酸(S1P)和溶血磷脂酸(LPA)以及胆固醇。还研究了它们对RAW 264.7巨噬细胞释放的细胞因子谱的影响。

结果

NAFLD患者红细胞条件生长培养基中的MCP1水平高于健康对照者(37±40 vs 6.51±5.63 pg/ml)。在S1P、LPA、胆固醇或其他八种细胞因子方面,患者与健康对照者之间未发现统计学上的显著差异。与患者来源的红细胞条件培养基孵育后,RAW 264.7细胞释放的TNF-a比来自健康或NAFLD受试者的无RAW 264.7细胞的培养基中更多。

结论

在NAFLD的背景下,红细胞可能通过单核细胞的肝脏浸润和巨噬细胞激活起作用,部分原因是CCL2的释放。

相似文献

3
Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease.
Front Immunol. 2022 May 6;13:880298. doi: 10.3389/fimmu.2022.880298. eCollection 2022.
7
Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice.
J Hepatol. 2018 Apr;68(4):773-782. doi: 10.1016/j.jhep.2017.11.040. Epub 2017 Dec 20.
9
Glycyrrhetinic acid regulates impaired macrophage autophagic flux in the treatment of non-alcoholic fatty liver disease.
Front Immunol. 2022 Jul 28;13:959495. doi: 10.3389/fimmu.2022.959495. eCollection 2022.
10
Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis.
Diabetologia. 2019 Nov;62(11):2143-2157. doi: 10.1007/s00125-019-4962-6. Epub 2019 Aug 6.

引用本文的文献

本文引用的文献

1
Angiotensin II-Induced Erythrocyte Senescence Contributes to Oxidative Stress.
Rejuvenation Res. 2022 Feb;25(1):30-38. doi: 10.1089/rej.2021.0054. Epub 2022 Jan 28.
3
Red Blood Cell Dysfunction in Non-Alcoholic Fatty Liver Disease: Marker and Mediator of Molecular Mechanisms.
Maedica (Bucur). 2020 Dec;15(4):513-516. doi: 10.26574/maedica.2020.15.4.513.
4
Immune and Metabolic Interactions of Human Erythrocytes: A Molecular Perspective.
Endocr Metab Immune Disord Drug Targets. 2021;21(5):843-853. doi: 10.2174/1871530320666201104115016.
5
Non-Alcoholic Fatty Liver Disease and Vascular Disease.
Curr Vasc Pharmacol. 2021;19(3):269-279. doi: 10.2174/1570161118666200318103001.
6
The Evolving Erythrocyte: Red Blood Cells as Modulators of Innate Immunity.
J Immunol. 2018 Sep 1;201(5):1343-1351. doi: 10.4049/jimmunol.1800565.
7
8
Extracellular vesicles in liver disease and potential as biomarkers and therapeutic targets.
Nat Rev Gastroenterol Hepatol. 2017 Aug;14(8):455-466. doi: 10.1038/nrgastro.2017.71. Epub 2017 Jun 21.
9
Extracellular Vesicles in Metabolic Syndrome.
Circ Res. 2017 May 12;120(10):1674-1686. doi: 10.1161/CIRCRESAHA.117.309419.
10
Inhibition of sphingosine 1-phosphate signaling ameliorates murine nonalcoholic steatohepatitis.
Am J Physiol Gastrointest Liver Physiol. 2017 Mar 1;312(3):G300-G313. doi: 10.1152/ajpgi.00222.2016. Epub 2016 Dec 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验